Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Anastrozole for prevention of breast cancer in high-risk postmenopausal women (IBIS-II): an international, double-blind, randomised placebo-controlled trial.

Cuzick J, Sestak I, Forbes JF, Dowsett M, Knox J, Cawthorn S, Saunders C, Roche N, Mansel RE, von Minckwitz G, Bonanni B, Palva T, Howell A; IBIS-II investigators..

Lancet. 2014 Mar 22;383(9922):1041-8. doi: 10.1016/S0140-6736(13)62292-8. Erratum in: Lancet. 2014 Mar 22;383(9922):1040.

2.

Long-term assessment of quality of life in the Intergroup Exemestane Study: 5 years post-randomisation.

Fallowfield LJ, Kilburn LS, Langridge C, Snowdon CF, Bliss JM, Coombes RC; IES Trial Steering Committee..

Br J Cancer. 2012 Mar 13;106(6):1062-7. doi: 10.1038/bjc.2012.43.

3.

Carpal tunnel syndrome and musculoskeletal symptoms in postmenopausal women with early breast cancer treated with exemestane or tamoxifen after 2-3 years of tamoxifen: a retrospective analysis of the Intergroup Exemestane Study.

Mieog JS, Morden JP, Bliss JM, Coombes RC, van de Velde CJ; IES Steering Committee..

Lancet Oncol. 2012 Apr;13(4):420-32. doi: 10.1016/S1470-2045(11)70328-X.

PMID:
22265698
4.

Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical trial at 8·1 years median follow-up.

Regan MM, Neven P, Giobbie-Hurder A, Goldhirsch A, Ejlertsen B, Mauriac L, Forbes JF, Smith I, Láng I, Wardley A, Rabaglio M, Price KN, Gelber RD, Coates AS, Thürlimann B; BIG 1-98 Collaborative Group.; International Breast Cancer Study Group (IBCSG)..

Lancet Oncol. 2011 Nov;12(12):1101-8. doi: 10.1016/S1470-2045(11)70270-4.

5.

The advantage of letrozole over tamoxifen in the BIG 1-98 trial is consistent in younger postmenopausal women and in those with chemotherapy-induced menopause.

Chirgwin J, Sun Z, Smith I, Price KN, Thürlimann B, Ejlertsen B, Bonnefoi H, Regan MM, Goldhirsch A, Coates AS; BIG 1-98 Collaborative and International Breast Cancer Study Groups..

Breast Cancer Res Treat. 2012 Jan;131(1):295-306. doi: 10.1007/s10549-011-1741-6.

7.

Pre-operative lymphoscintigraphy before sentinel lymph node biopsy for breast cancer.

Mathew MA, Saha AK, Saleem T, Saddozai N, Hutchinson IF, Nejim A.

Breast. 2010 Feb;19(1):28-32. doi: 10.1016/j.breast.2009.10.002.

PMID:
19913418
8.

Letrozole therapy alone or in sequence with tamoxifen in women with breast cancer.

BIG 1-98 Collaborative Group., Mouridsen H, Giobbie-Hurder A, Goldhirsch A, Thürlimann B, Paridaens R, Smith I, Mauriac L, Forbes J, Price KN, Regan MM, Gelber RD, Coates AS.

N Engl J Med. 2009 Aug 20;361(8):766-76. doi: 10.1056/NEJMoa0810818.

9.

Design, conduct, and analyses of Breast International Group (BIG) 1-98: a randomized, double-blind, phase-III study comparing letrozole and tamoxifen as adjuvant endocrine therapy for postmenopausal women with receptor-positive, early breast cancer.

Giobbie-Hurder A, Price KN, Gelber RD; International Breast Cancer Study Group.; BIG 1-98 Collaborative Group..

Clin Trials. 2009 Jun;6(3):272-87. doi: 10.1177/1740774509105380.

10.

Bone fractures among postmenopausal patients with endocrine-responsive early breast cancer treated with 5 years of letrozole or tamoxifen in the BIG 1-98 trial.

Rabaglio M, Sun Z, Price KN, Castiglione-Gertsch M, Hawle H, Thürlimann B, Mouridsen H, Campone M, Forbes JF, Paridaens RJ, Colleoni M, Pienkowski T, Nogaret JM, Láng I, Smith I, Gelber RD, Goldhirsch A, Coates AS; BIG 1-98 Collaborative and International Breast Cancer Study Groups..

Ann Oncol. 2009 Sep;20(9):1489-98. doi: 10.1093/annonc/mdp033.

11.

No socioeconomic inequalities in colorectal cancer survival within a randomised clinical trial.

Nur U, Rachet B, Parmar MK, Sydes MR, Cooper N, Lepage C, Northover JM, James R, Coleman MP; AXIS collaborators..

Br J Cancer. 2008 Dec 2;99(11):1923-8. doi: 10.1038/sj.bjc.6604743.

12.

Prognostic and predictive value of centrally reviewed Ki-67 labeling index in postmenopausal women with endocrine-responsive breast cancer: results from Breast International Group Trial 1-98 comparing adjuvant tamoxifen with letrozole.

Viale G, Giobbie-Hurder A, Regan MM, Coates AS, Mastropasqua MG, Dell'Orto P, Maiorano E, MacGrogan G, Braye SG, Ohlschlegel C, Neven P, Orosz Z, Olszewski WP, Knox F, Thürlimann B, Price KN, Castiglione-Gertsch M, Gelber RD, Gusterson BA, Goldhirsch A; Breast International Group Trial 1-98..

J Clin Oncol. 2008 Dec 1;26(34):5569-75. doi: 10.1200/JCO.2008.17.0829.

13.

Timing of breast cancer surgery in relation to menstrual cycle phase: no effect on 3-year prognosis: the ITS Study.

Thorpe H, Brown SR, Sainsbury JR, Perren TJ, Hiley V, Dowsett M, Nejim A, Brown JM.

Br J Cancer. 2008 Jan 15;98(1):39-44.

14.

Massive hemoperitoneum caused by rupture of an aneurysm of the marginal artery of Drummond.

Abdelrazeq AS, Saleem TB, Nejim A, Leveson SH.

Cardiovasc Intervent Radiol. 2008 Jul;31 Suppl 2:S108-10.

PMID:
17710481
15.

Follow up of patients with colorectal polyps: are the BSG guidelines being adhered to?

Pickard M, Dewar EP, Kapadia RC, Khan RB, Hutchinson IF, Nejim A.

Colorectal Dis. 2007 Mar;9(3):203-6.

PMID:
17298616
16.

Hepatic artery aneurysm: an unusual cause for gastrointestinal haemorrhage.

Narula HS, Kotru A, Nejim A.

Emerg Med J. 2005 Apr;22(4):302.

17.
18.

Clinical economics review: the health-care economic implications of minimal access gastrointestinal surgery.

Guillou PJ, Windsor AJ, Nejim A.

Aliment Pharmacol Ther. 1996 Oct;10(5):707-13. Review.

PMID:
8899077

Supplemental Content

Loading ...
Support Center